The global dermatophytic onychomycosis treatment market size was valued at US$ 2,596.8 million in 2017, and is expected to witness a CAGR of 12.6% over the forecast period 2018 – 2026.

The global Tylosin market size was valued at US$ 379.0 million in 2017, and is expected to witness a CAGR of 1.2% over the forecast period 2018 – 2026.

The global hormone replacement therapy market size was valued at US$ 10.58 billion in 2017 and is expected to witness a CAGR of 5.2% over 2018 – 2026.

The global ranitidine market size was valued at US$ 412.4 Mn in 2017, and is expected to witness a CAGR of 1.8% over the forecast period 2018 – 2026.

The global PET-CT scanner device market size was valued at US$ 1.9 billion in 2017 and is expected to witness a CAGR of 5.1% over the forecast period 2018 – 2026.

The global ursodeoxycholic acid market size was valued at US$ 457.3 million in 2017 and is expected to exhibit a CAGR of 10.1% over the forecast period 2018 – 2026.

The global nonalcoholic steatohepatitis treatment market size was valued at US$ 1,119.9 million in 2017 and is expected to witness a CAGR of 42.7% over the forecast period (2018 – 2026).

The global pipettes and accessories market size was valued at US$ 1.3 billion in 2017 and is expected to witness a CAGR of 4.0% over 2018 – 2026.

The global cardiac rhythm management devices market size was valued at US$ 19.05 billion in 2017, and is expected to witness a CAGR of 7.5% By 2026.

The global omeprazole market size was valued at US$ 2,668.4 million in 2017, and is expected to exhibit a CAGR of 5.2% over 2018 – 2026.

Global central venous catheter market size was valued at US$ 1,167.4 million in 2017, and is expected to exhibit a CAGR of 6.2% over 2018-2026.

Global stem cell cartilage regeneration market size was valued at US$ 254.4 million in 2017, and is expected to witness a CAGR of 8.9% over 2018 – 2026.

The global pemetrexed market size was valued at US$ 2062.5 Mn in 2017 and is expected to witness a CAGR of 1.3% during the forecast period 2018 – 2026.

The global hemophilia gene therapy market was valued at US$ 0.00 million in 2017 and is expected to witness a CAGR of 56.0% over 2018 – 2026.

The global neuroscience market size was valued at US$ 26,593 million in 2017, and is expected to witness a CAGR of 3.9% By 2026.

The global minimally invasive surgical instruments market size was valued at US$ 12,878.3 million in 2017, and is expected to witness a CAGR of 6.1% over the forecast period (2018 – 2026).

The palliative care market revenue is expected to witness significant growth over the forecast period, owing to increasing demand for palliative care centers by patients suffering from chronic illness.

Key players are constantly focused on developing novel approaches for treatment of nasal polyps, which is expected to impel the global nasal polyps’s treatment market growth.

Increasing prevalence of kidney and other renal disorders is expected to drive growth of the Foley catheters market during the forecast period.

Jak inhibitors are increasingly preferred for industrial research due to their critical role in immune response signaling.

Androgens are male sex hormones responsible for masculine characteristics such ad muscular build, deeper voice, and facial hair.

The global cordyceps sinensis and militaris extract market size was valued at US$ 473.4 million in 2018, and is expected to witness a CAGR of 10.4% during 2018 – 2026.

The global hepatic encephalopathy market was valued at US$ 2,408.3 Mn in 2017, and is expected to witness a CAGR of 6.3% during 2018 – 2026.

The global heparin market size was valued at US$ 9.4 billion in 2017 and is expected to witness a CAGR of 5.1% over the forecast period 2018 – 2026.

Increasing drug approvals by regulatory authorities is expected to boost the global chronic inflammatory demyelinating polyneuropathy (CIDP) treatment market growth.

The global suprapubic catheter market was valued at US$ 11,265.4 million in 2017 and is expected to witness a CAGR of 7.3% during 2018 – 2026.

Increasing prevalence of diseases such as cancer is expected to propel the global Fc protein and glycoengineered antibodies market growth.

Increase in adoption of androstenedione as a dietary supplement is major factor driving growth of the global androstenedione market.

Strategies such as partnerships, collaborations, mergers, and acquisitions, adopted by the key players are expected to drive the global hemodialysis market growth.

Increasing prevalence of road side accidents and sport injuries is expected to drive the global foot and ankle devices market over the forecast period.

Medical lifting sling, also known as patient lift or sling lift, is a device used as a support for patients, which are unable to perform daily activities requiring movement.

The global custom recombinant protein production services market size was valued at US$ 2,600.21 million in 2017, and is expected to exhibit a CAGR of 11.2% By 2026.

Approvals of the drugs by regulatory bodies for the treatment of Hodgkin’s lymphoma is expected to drive the global Hodgkin’s lymphoma market growth.

The global infertility drugs market size was valued at US$ 3.8 billion in 2017, and is expected to witness a CAGR of 5.8% By 2026.

Medical vacuum system is designed to remove unwanted fluids or gases from hospitals and laboratories.

Healthcare education solution is designed to help individuals and communities. Healthcare education gives information about the physical, mental, emotional, and social health.

Technological advancements in detection of dental caries is expected to fuel growth of the dental caries detectors market.

The global infectious disease diagnostics market size was valued at US$ 15,112.2 million in 2017, and is expected to witness a robust CAGR of 6.1% By 2026.

Theranostics include use of specific diagnostic test, which shows a particular molecular target on a tumor or any other disease causing agent.

Precision medicine diagnostics market is expected to expand at rapid pace in near future, owing to increasing number of pipeline studies to develop new treatment for cancer.

Asia Pacific newborn screening market size was valued at US$ 171.3 million in 2017 and is expected to witness a CAGR of 12.7% By 2026.

The global neuroendocrine tumor treatment market was valued at US$ 1,197.3 million in 2015 and is expected to witness a CAGR of 10.5% By 2025

Increasing diabetes incidence and rising obesity driving growth of the bone degeneration therapeutics market

The Latin America bone graft and substitutes market was valued at US$ 116.8 million in 2018, and is expected to witness a CAGR of 5.6% By 2026.

Increasing prevalence of stroke incidences in growing geriatric population is another major factor driving the market size.

The global stem cell cartilage regeneration market size was valued at US$ 254.4 million in 2017, and is expected to witness a CAGR of 8.9% By 2026.

Advancements in research and development for developing innovative technology for nerve biologic products are expected to drive growth of the nerve biologic product market.

The global recombinant therapeutic antibodies and proteins market size was valued at US$ 91.2 billion in 2017, and is expected to witness a robust CAGR of 12.2% By 2026

Increasing incidence of autoimmune diseases such as plaque psoriasis and rheumatoid arthritis are expected to drive growth of the Remicade biosimilar market size.

Enzyme replacement therapy involves intravenous administration of enzymes in order to correct the deficiency of enzymes that causes a specific disease condition called lysosomal storage disease.